Ifosfamide encephalopathy presenting with asterixis.
CNS toxic effects of the antineoplastic agent ifosfamide (IFX) are frequent and include a variety of neurological symptoms that can limit drug use. We report a case of a 51-year-old man who developed severe, disabling negative myoclonus of the upper and lower extremities after the infusion of ifosfamide for plasmacytoma. He was awake, revealed no changes of mental status and at rest there were no further motor symptoms. Cranial magnetic resonance imaging and extensive laboratory studies failed to reveal structural lesions of the brain and metabolic abnormalities. An electroencephalogram showed continuous, generalized irregular slowing with admixed periodic triphasic waves indicating symptomatic encephalopathy. The administration of ifosfamide was discontinued and within 12 h the asterixis resolved completely. In the patient described, the presence of asterixis during infusion of ifosfamide, normal laboratory findings and imaging studies and the resolution of symptoms following the discontinuation of the drug suggest that negative myoclonus is associated with the use of IFX.
Meyer
Thomas
T
Department of Neurology, Charité Hospital, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany. thomas.meyer@charite.de
Ludolph
Albert C
AC
Münch
Christoph
C
D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis; D020820:Dyskinesias / Q000175:diagnosis / Q000209:etiology*; D004569:Electroencephalography / Q000187:drug effects; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009207:Myoclonus / Q000139:chemically induced / Q000175:diagnosis; D020258:Neurotoxicity Syndromes / Q000150:complications* / Q000175:diagnosis*; D010954:Plasmacytoma / Q000188:drug therapy*; D012075:Remission, Spontaneous
D007069:Ifosfamide